Pharmacovigilance Market Revenue 2024 to 2034
Pharmacovigilance Market Revenue 2024 to 2034
The pharmacovigilance market will expand from USD 9.5 Bn in 2024 to USD 22.25 Bn by 2034, at an 8.88% CAGR, fueled by stricter regulations, rising adverse drug reaction monitoring, and outsourcing by pharmaceutical firms.
Report ID: 10666
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 9.50 Bn
Forecast Year,
USD 22.25 Bn
CAGR, 2025 -
8.88%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Pharmacovigilance Market Size Analysis
Pharmacovigilance Market Size By Service Provider 2024 to 2034 (USD )
| Service Provider | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| In-house | 6.55 | 7.13 | 7.74 | 8.44 | 9.15 | 10.16 | 10.89 | 11.77 | 13.08 | 14.88 | 15.60 |
| Contract Outsourcing | 2.95 | 3.22 | 3.53 | 3.83 | 4.21 | 4.38 | 4.94 | 5.46 | 5.69 | 5.56 | 6.65 |
Pharmacovigilance Market Size By Clinical Trial Phase 2024 to 2034 (USD )
| Clinical Trial Phase | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Preclinical | 1.54 | 1.69 | 1.79 | 2.10 | 2.11 | 2.35 | 2.75 | 2.78 | 2.80 | 2.81 | 3.66 |
| Phase I | 0.19 | 0.22 | 0.24 | 0.26 | 0.44 | 0.16 | 0.27 | 0.61 | 1.16 | 0.65 | 0.41 |
| Phase II | 1.22 | 1.35 | 1.44 | 1.49 | 1.62 | 1.93 | 2.19 | 2.44 | 2.24 | 2.80 | 2.77 |
| Phase III | 4.31 | 4.66 | 5.09 | 5.57 | 6.01 | 6.73 | 7.07 | 7.62 | 7.87 | 9.26 | 10.46 |
| Phase IV | 2.23 | 2.41 | 2.69 | 2.85 | 3.17 | 3.36 | 3.55 | 3.78 | 4.70 | 4.91 | 4.95 |
Pharmacovigilance Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Spontaneous Reporting | 1.81 | 1.99 | 2.13 | 2.33 | 2.46 | 2.80 | 3.09 | 3.23 | 3.76 | 3.58 | 4.05 |
| Targeted Spontaneous Reporting | 3.89 | 4.23 | 4.70 | 4.92 | 5.52 | 5.81 | 6.58 | 6.61 | 7.64 | 8.65 | 9.18 |
| Cohort Event Monitoring | 2.59 | 2.79 | 2.99 | 3.38 | 3.61 | 3.75 | 4.39 | 5.00 | 5.28 | 5.75 | 6.59 |
| EHR Mining | 1.20 | 1.34 | 1.45 | 1.63 | 1.76 | 2.17 | 1.78 | 2.39 | 2.09 | 2.46 | 2.44 |
Pharmacovigilance Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.58 | 2.84 | 3.04 | 3.34 | 3.68 | 3.83 | 4.31 | 4.90 | 4.94 | 5.28 | 5.91 |
| Europe | 0.94 | 1.01 | 1.09 | 1.00 | 1.34 | 1.43 | 1.80 | 2.06 | 2.08 | 1.30 | 1.79 |
| Asia Pacific | 2.75 | 2.99 | 3.29 | 3.66 | 3.86 | 4.22 | 4.43 | 4.70 | 5.12 | 6.48 | 6.64 |
| Latin America | 1.58 | 1.72 | 1.87 | 2.19 | 2.26 | 2.65 | 2.53 | 2.64 | 3.15 | 2.99 | 3.71 |
| Middle East & Africa | 1.64 | 1.77 | 1.98 | 2.07 | 2.22 | 2.41 | 2.76 | 2.94 | 3.47 | 4.38 | 4.19 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
